121689-22-3 Usage
Uses
Used in Pharmaceutical Synthesis:
8-Nitroquinoline-4-carboxylic acid is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Production:
In the agrochemical industry, 8-Nitroquinoline-4-carboxylic acid is utilized as a building block for the creation of compounds that can be used in pest control and crop protection, leveraging its chemical properties to enhance agricultural productivity.
Used in Organic Synthesis:
8-Nitroquinoline-4-carboxylic acid is employed as a versatile intermediate in organic synthesis, allowing for the construction of a wide array of organic compounds for various applications, including the development of new materials and chemical products.
Used in Research and Development:
8-Nitroquinoline-4-carboxylic acid plays a significant role in research and development, particularly in medicinal chemistry, where it aids in the exploration of novel chemical entities and the advancement of organic synthesis techniques.
Check Digit Verification of cas no
The CAS Registry Mumber 121689-22-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,6,8 and 9 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 121689-22:
(8*1)+(7*2)+(6*1)+(5*6)+(4*8)+(3*9)+(2*2)+(1*2)=123
123 % 10 = 3
So 121689-22-3 is a valid CAS Registry Number.
121689-22-3Relevant academic research and scientific papers
Novel Sulfonaminoquinoline Hepcidin Antagonists
-
Page/Page column 173, (2012/09/05)
The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.
Carbapenem antibiotic compounds
-
, (2008/06/13)
The present invention relates to carbapenems and provides a compound of the formula (I) STR1 wherein: R1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R2 is hydrogen or C1-4 alkyl; R3 is hydrogen or C1-4 alkyl; P1 is of the formula: STR2 and one or two of A,B,C,D,E,F,G and H, are nitrogen and the remainder are CH; and P is bonded to the nitrogen of the linking carbamoyl group by a carbon atom, in either ring, is substituted by the carboxy group on a carbon atom, in either ring, and is optionally further substituted, by up to three substitutents, on a carbon atom, in either ring; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof. Processes for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them are also described.
